glp 1 agonist alcohol GLP-1 Therapeutics and Their Emerging Role in and Substance Use Disorders: An Endocrinology Primer IUPHAR review – Glucagon-like peptide-1
Description
Stromberg, Z
Authors UH, AV, and MBu were employed by Synovo GmbH
170 Diabetes may exacerbate the progression of PD, including cognitive impairment and axial motor symptoms
Nally LM, Sherr JL, Van Name MA, Patel AD, Tamborlane WV (2019) Pharmacologic treatment options for type 1 diabetes: whats new
doi: 10.1038/ijo.2011.158 240 BlundellJFinlaysonGAxelsenMFlintAGibbonsCKvistTet al
